US Patent 7202331 Therapeutic anti-cytomegalovirus compounds

Patent 7202331 was granted and assigned to Genzyme on April, 2007 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 28 Aug, 2024

"update inverses"

Golden AI

edited on 28 Aug, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 12070496 Compositions, methods and kits for eliciting an immune response

Edits on 6 Sep, 2023

"Add patent inventor(s)"

Golden AI

edited on 6 Sep, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Inventor Names

Charles A. Nicolette0

Edits on 1 Sep, 2023

"Add patent abstract"

Golden AI

edited on 1 Sep, 2023

Edits made to:

Article (+411 characters)

Article

Patent abstract

The present invention provides synthetic compounds, antibodies that recognize and bind to these compounds, polynucleotides that encode these compounds, and immune effector cells raised in response to presentation of these epitopes. The invention further provides methods for inducing an immune response and administering immunotherapy to a subject by delivering the compositions of the invention.

Edits on 24 May, 2023

"Remove website redirecting to Patent Public Search front page"

Golden AI

edited on 24 May, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=072023310

Edits on 23 May, 2023

"Remove leading 0 from patent number"

Golden AI